Novavax Reports Upbeat Trial Results
Novavax Inc. (NVAX) reported upbeat results for its vaccine against a strain of avian flu sending the stock price soaring 60 cents to $3.19.
posted by FC Market News at 9:30 AM
Monday, April 02, 2007
Previous Posts
- Medarex Reports Positive Results
- Magma Settles Dispute With Synopsys
- Revenue Falls Short For Global Payments
- ICT Slashes Outlook
- Earnings Double For Checkpoint Systems
- Approval Recommended For Dendreon's Provenge
- KMG's Rating Lowered
- Gol Linhas To Acquire Varig
- U. S. Steel To Acquire Lone Star
- Insituform Warns Of Lower Earnings
0 Comments:
Post a Comment
<< Home